Please check your internet connection and try again.
## Lorazepam (a representative benzodiazepine)
### Overview
Lorazepam is a short-acting benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, anticonvulsant, and muscle relaxant properties. It is metabolized by glucuronidation, which is less affected by liver dysfunction compared to other benzodiazepines.
### Primary Indications
* Anxiety disorders
* Insomnia due to anxiety or transient situational stress
* Management of seizures, including status epilepticus
* Premedication for surgical procedures
* Management of agitation
### Adult Dosing
Dosing is highly individualized and depends on the indication, patient factors, and response.
* **Anxiety:** 1-4 mg orally every 6-8 hours. Maximum daily dose typically 10 mg.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Premedication (Surgery):** 2-4 mg orally 2 hours before procedure.
* **Agitation:** 1-4 mg orally or IM every 4-6 hours as needed.
* **Status Epilepticus:** 4 mg IV or IM initially. May repeat in 5-10 minutes if seizures persist, not to exceed 8 mg in a 12-hour period. **Intravenous administration should be slow (e.g., 2 mg/min) to minimize respiratory depression.**
### Pediatric Dosing
Dosing in children is not well established and requires careful consideration of risks and benefits.
* **Seizures (Status Epilepticus):** 0.05-0.1 mg/kg IV or IM, not to exceed 4 mg per dose. May repeat once after 5-10 minutes if seizures persist. **Use with extreme caution in neonates and infants due to increased risk of respiratory depression and apnea.**
### Dose Adjustments
* **Hepatic Impairment:** No dose adjustment generally needed due to glucuronidation metabolism. However, caution is advised, and lower doses may be appropriate.
* **Renal Impairment:** No dose adjustment generally needed.
* **Elderly:** Start with lower doses (e.g., 0.5-1 mg PO BID) and titrate slowly due to increased sensitivity to CNS depressant effects.
### Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency (relative contraindication, use with caution).
* Myasthenia gravis.
* Sleep apnea.
### Adverse Effects
* **Common:** Sedation, drowsiness, dizziness, fatigue, ataxia, decreased coordination.
* **Serious:** Respiratory depression, paradoxical excitation, anterograde amnesia, dependence and withdrawal symptoms upon abrupt discontinuation.
### Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, barbiturates, antihistamines):** Additive sedative and respiratory depressant effects. Concomitant use with opioids significantly increases the risk of respiratory depression, sedation, coma, and death.
* **Theophylline and Aminophylline:** May reduce the sedative effects of lorazepam.
* **Valproic acid:** May increase plasma concentrations of lorazepam.
### Monitoring
* Respiratory rate, depth, and oxygen saturation, especially with IV administration or in combination with other CNS depressants.
* Level of sedation and cognitive function.
* Signs of dependence and withdrawal if used long-term.
### Clinical Pearls
* Lorazepam is available in oral, intramuscular, and intravenous formulations. IM injection is reliable. IV administration should be slow to prevent apnea.
* Due to its short half-life, lorazepam is generally not preferred for long-term management of insomnia compared to agents with longer half-lives.
* Abrupt discontinuation after prolonged use can lead to withdrawal symptoms including anxiety, insomnia, tremors, muscle cramps, and potentially seizures. Tapering is recommended.
* Lorazepam may exacerbate depression.
---
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for complete details before making any treatment decisions.
